Fingerprint
Dive into the research topics of 'ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
Robert C. Sergott*, Jeffrey L. Bennett, Peter Rieckmann, Xavier Montalban, Daniel Mikol, Ulrich Freudensprung, Thomas Plitz, Johan Van Beek
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
69
Citations
(Scopus)